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Background: Coronary artery bypass grafting (CABG) with cardioplegic cardiac arrest and cardiopulmonary bypass
(CPB) is associated with myocardial injury. The aim of this study was to investigate whether a modified mechanical
post-conditioning (MMPOC) technique has a myocardial protective effect by enhancing early metabolic recovery of
the heart following revascularization.
Methods: A prospective, randomized trial was conducted at a single-center university hospital performing adult
cardiac surgery. Seventy-nine adult patients undergoing first-time elective isolated multivessel coronary artery
bypass grafting were prospectively randomized to MMPOC or control group. Anesthetic, cardiopulmonary bypass,
myocardial protection, and surgical techniques were standardized. The post reperfusion cardiac indices, inotrope
use and biochemical-electrocardiographic evidence of myocardial injury were recorded. The incidence of
postoperative complications was recorded prospectively.
Results: Operative characteristics, including CPB and aortic cross-clamp time, were similar between the two groups
(p>0.05). The MMPOC group had lower troponin I and other cardiac biomarkers level post CPB and postoperatively,
with greater improvement in cardiac indices (p<0.001). MMPOC shortened post surgery hospitalization from
9.1 ± 2.1 to 7.5 ± 1.6 days (p<0.001).
Conclusions: MMPOC technique promotes early metabolic recovery of the heart during elective CABG, leading to
better myocardial protection and functional recovery.
Keywords: Cardiopulmonary bypass, Myocardial protection, Ischemia-reperfusion injury, Coronary artery bypass
grafting, Post-conditioningBackground
Reperfusion has the potential to cause additional revers-
ible and irreversible damage to the myocardium, which
is called reperfusion injury [1,2]. The existence of post-
conditioning (POC) is the newest evidence that has
emerged to support the concept of reperfusion injury.* Correspondence: serkandurdu@gmail.com
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reproduction in any medium, provided the orThe term post conditioning refers to the phenomenon
in which multiple brief periods of reperfusion inter-
spersed with brief periods of ischemia (10–60 s) result in
a reduction in infarct size [3,4]. Generally, three cycles
of ischemia/reperfusion are required to produce a max-
imal POC effect, although four and six cycles have been
shown to be effective by some investigators [3,4]. How-
ever, it is the interval of reperfusion and ischemia that is
the most critical factor in determining how efficacious
POC will be. POC protocols shown to be maximally
effective at reducing infarct size range from 10 to 60 s
depending on the specific species being studied [3,4].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of a modified type of mechanical post-conditioning
(MMPOC) in patients undergoing elective coronary
revascularization, with specific attention to biochemical
markers of ischemic injury and post-surgical recovery
of the patients and to show whether there is room for




This study was approved by the Institutional Review
Board of the University of Ankara and consisted of 79
patients undergoing elective primary coronary revascu-
larization with ≥99% stenosis of the left anterior des-
cending (LAD) artery. So as to include patients with
relatively large volumes of at-risk myocardium, we lim-
ited our analysis to those patients exhibiting proximal
occlusion of the LAD. Patients undergoing valve replace-
ment, combined valve replacement/coronary revasculari-
zation, or preoperative coronary revascularization was
excluded from the study. Informed consent was obtained
from all patients before enrollment.
Randomisation
Patients were allocated to the MMPOC group or the
study group using a computer-generated randomization
code. Participants were randomly assigned in a 1:1 ratio.
The study was open label and the primary investigator,
who was not the treating physician and nurses informed
the participants about their allocated treatment. Data for
primary outcomes were assessed by use of a computer.
Data collection and definitions
Baseline, procedural, and follow-up data were stored pro-
spectively in a database located at the University of An-
kara. Patients’ preoperative risk factors were recorded
and EuroSCOREs were calculated for each patient.
Patients’ preoperative characteristics were recorded in-
cluding age, sex, size, preexisting medical conditions,
preoperative medications, preoperative ejection fractions.
Intraoperative variables of which number of coronary by-
pass grafts, duration of cardiopulmonary bypass (CPB),
duration of aortic cross-clamp, requirement for inotropic
drugs, and/or intra-aortic balloon support, and blood
product use were included. Postoperative data comprised
myocardial infarction, cardiac tamponade, reoperation
for occlusion or other causes, requirement of intra-aortic
balloon pump support, neurologic complications, renal
dysfunction, chest tube drainage during the first 24 post-
operative hours, total chest tube drainage, the length of
mechanical ventilator support, pneumonia, multiorgan
failure, gastrointestinal complications, sepsis, coma, thelength of intensive care unit (ICU) stay, and readmission
within 90 days after surgery.
Adverse events were defined as death, perioperative
myocardial infarction, stroke, re-exploration due to
bleeding, respiratory insufficiency, and renal failure.
Perioperative myocardial infarction (MI) was defined as
either new Q waves or ischemic ST segment changes
with concomitant elevations of creatine kinase isoen-
zyme (CK-MB) > 5 times the upper limit of the reference
range or a CK-MB to total creatine kinase (CK) ratio >
10% occurring within 48 hours after surgery or troponin
I (TnI) > 1 ng/mL. Renal dysfunction was defined as rise
of serum creatinine above 2.5 mg/dL and/or a need for
hemodialysis. The surgical team examined all patients
about 4-6 weeks after discharge and annually thereafter
for two years.
Anesthetic and surgical considerations
Anesthesia was maintained with isoflurane. Hyperten-
sion was treated by increasing the concentration of iso-
flurane or by the administration of nitroglycerin if
increasing the depth of anesthesia was ineffective.
Hypotension was corrected using volume replacement
or phenylephrine, as clinically indicated. An additional
dose of 5 mg of midazolam was provided during
rewarming from CPB. Inotropic agents (dobutamine
5 μg/kg/min) were initiated for a cardiac indices (CI)
<2.0 L/min/m2 after separation from CPB. At sternal
closure, an infusion of propofol was started (25-75 μg/
kg/min), and the isoflurane was discontinued. Propofol
sedation was continued in the ICU until weaning of ven-
tilatory support was initiated.
All patients had coronary artery bypass grafting
(CABG) with the use of CPB, which was conducted with
a roller pump and a membrane oxygenator primed with
a solution consisting of 1 L of Ringer’s lactate, 5000 IU
of heparin, 750 mL of Pentaspan (DuPont Pharmaceuti-
cals Co, Newark, DE), and 44 mEq of bicarbonate. Dur-
ing CPB, pump flow was set at 2.4 times the body
surface area, and mean arterial pressure maintained be-
tween 50 and 60 mm Hg. The temperature was allowed
to drift with active rewarming at the end of CPB. Cardi-
oplegia solution (Plegisol, Hospira,Inc, Lake Forest, IL),
which was used at the discretion of the cardiac surgeon,
was free of glucose and consisted of high-dose
(100 mEq/L) and low-dose (40 mEq/L) potassium. Car-
dioplegia was given in an anterograde fashion with blood
in a ratio of 1:4. Blood cardioplegia was also adminis-
tered with each successive distal vein graft anastomosis.
The proximal vein graft anastomosis were performed
after the distal ones under tangential aortic clamp. The
left internal thoracic artery was used in all cases to by-
pass the LAD, while other coronary arteries received sa-
phenous vein grafts. In patients with severe aortic
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ful, we used the MMPOC technique immediately after
completion of the proximal anastomosis and weaning off
CPB, in the MMPOC group we applied bulldog clamps
to the grafts anatomized to the coronary arteries as in a
similar manner and duration explained by Zhao et al be-
fore 2 [4]. Our MMPOC technique consisted of applying
three 30-sec alternate episodes of occlusion with bulldog
clamps and releasing of the bypassed grafts providing
reperfusion. This method was applied immediately after
CPB and in this way uncontrolled reperfusion was disal-
lowed in the study group (Figure 1). This method was
applied immediately after CPB and in this way uncon-
trolled reperfusion wasn’t permitted in the study group.
Functional recovery and postoperative cardiac biomarkers
The CI, hemodynamic parameters and cardiac biomarkers
were evaluated in 9 different time points (immediately
after the induction of anesthesia; following completion of
the proximal anastomosis; immediately off CPB; immedi-
ately after MMPOC; 2, 6, 12, 24, and 48 hours-post
MMPOC). The CI was calculated to determine the change
in the CI as an indicator of functional recovery. Central
venous pressure (CVP), mean pulmonary artery pressure
(MPAP) and pulmonary capillary wedge pressure (PCWP)
measurements were compared at the same time points to
ensure similar preload filling status.
The baseline values of serum CK-MB, and TnI con-
centration were taken as described above. All the TnI
samples were stored deep-frozen for quantitative ana-
lysis. TnI was analyzed using an AxSYM TnI Reagent
Kit as a micro particle enzyme immunoassay method
and an AxZYM analyzer (Abbott Laboratories, Abbot
Park, IL). The upper reference limit was 0.50 g/L, andFigure 1 The Modified Mechanical Postconditioning (MMPOC) Protoc
Control group (n = 40) using a computer-generated randomization code. D
and after wean off CPB phase, three cycle of bulldog clamping of anastom
Then, clinical outcomes of the patients were recorded.the cutoff limit for diagnosing acute myocardial infarc-
tion was 1.00 [g/L].Sample size and randomisation
A repeated measures design has MMPOC and control
groups of 39 and 40 subjects respectively for a total of
79 patients. Each subject is measured 6 times. The
between-subject standard deviation is 0.41 and the
within-subject standard deviation is 1.00. This design
achieves 96% power when an F test is used to test the
group-factor at a 5% significance level and the actual
standard deviation among the appropriate means is 0.17
(an effect size of 0.42), achieves 91% power when an F
test is used to test the time-factor at a 5% significance
level and the actual standard deviation among the ap-
propriate means is 0.19 (an effect size of 0.19), and
achieves 83% power when an F test is used to test the
(group X time) interaction at a 5% significance level and
the actual standard deviation among the appropriate
means is 0.17 (an effect size of 0.17) [5].Statistical analysis
Nominal variables were assessed by Chi square test or
Fisher’s Exact test, where applicable. Continuous and or-
dinal variables were evaluated between two groups by
Student’s t test and Mann–Whitney U test, respectively.
Two-way analysis of variance (ANOVA) for repeated
measures was used to assess the main effect of time as
within-factor and post conditioning versus control as
grouping factor and interactions between them (group X
time). If a significant effect was detected, pair wise com-
parisons were evaluated using the Bonferroni test. A p
value less than 0.05 was considered significant. Allol. Patients were allocated to the MMPOC group (n = 39) or the
uring MMPOC protocol, proximal bypass anastomosis were completed
osis for 30 seconds and anastomosis were reperfused for 30 seconds.
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(SPSS Inc, Chicago, Illinois, USA).
Results
The patient characteristics as well as preoperative car-
diac biomarkers and hemodynamic variables were simi-
lar within each study group (p>0.05) (Table 1 and
Figure 2 A,B,C). The kinetics of cardiac biomarkers fol-
lowed almost the same route and remained lower in the
study group throughout the study period. But statisti-
cally significant differences occurred in different time
points. CK and CK-MB remained lower in the study
group from the 6th and 12th post-conditioning hours till
the end of the study respectively in the MMPOC group
(p<0.001). Although TnI levels remained lower in the
study group, the values reached statistical difference
after the 24th hours (p<0.001) (Figure 2 A,B,C).Table 1 Patient Characteristics
M








LMCA disease n (%)
History of Hypertension n (%)
Diabetes Mellitus n (%)
Hb (g/dl) Mean± SD
Median (Min-Max)
Glucose (mg/dl) Mean± SD
Median (Min-Max)
Creatinine (mg/dl) Mean± SD
Median (Min-Max)
BUN (mg/dl) Mean± SD
Median (Min-Max)
Protein (mg/dl) Mean± SD
Median (Min-Max)




SD= standard deviation, Min=minimum, Max: maximum, MMPOC=modified mecha
ventricular ejection fraction, LMCA= left main coronary artery, Hb=hemoglobin, BU
Nominal variables were assessed by Chi square test or Fisher’s Exact test, where app
by Student’s t test and Mann–Whitney U test, respectively.Intraoperative characteristics
The CPB time was not statistically different between
the groups (p = 0.062) nor was the aortic cross-clamp
time (p = 0.082). The mean number of grafts was
similar between the groups (p = 0.974). The operative
time was shorter in the MMPOC group (Table 2),
however it was statistically insignificant (p = 0.619).
This period also include the post conditioning time.
CI were comparable between the two groups in the
first period (2.01 ± 0.10 L/min/m2 in MMPOC group
versus 1.99 ± 0.09 L/min/m2 in control group,
p = 0.362). Under the similar preload filling status,
patients in MMPOC group had higher post-
conditioning CI in all time points (p<0.001). The ac-
tual values of PCWP, MPAP and CVP remained
similar between the two groups in all time points
(p>0.05) (Figure 3 A,B,C,D).MPOC (n, 39) Control (n, 40) P Value
61.6 ± 8.1 62.4 ± 7.1 0.833
62 (45-73) 63 (48-77)
1.87 ± 0.76 1.72 ± 0.67 0.431
2 (1-4) 2 (1-3)
47.6 ± 5.5 46.1 ± 5.7 0.185
48 (38-57) 44.5 (39-57)
3.05 ± 1.37 2.67 ± 1.42 0.193
3 (1-6) 2 (1-6)
3 (7.7) 2 (5.0) 0.675
15 (38.5) 17 (42.5) 0.715
15 (38.5) 17 (42.5%) 0.715
12.1 ± 0.46 12.3 ± 0.57 0.358
12.3 (10.6-13.1) 12.3 (11.8-14.5)
101.4 ± 14.8 98 ± 12.1 0.376
98 (75-131) 95 (75-125)
1.13 ± 0.19 1.15 ± 0.15 0.484
1.1 (0.8-1.8) 1.2 (0.9-1.4)
25.6 ± 4.9 26.5 ± 5.1 0.421
25 (14-36) 25 (20-34)
6.60 ± 0.19 6.61 ± 0.22 0.841
6.6 (6.1-7.0) 6.7 (6.2-7.2)
3.50 ± 0.20 3.46 ± 0.13 0.277
3.5 (3.0-3.9) 3.4 (3.3-3.8)
1.05 ± 0.07 1.03 ± 0.07 0.450
1.02 (0.9-1.3) 1.02 (0.8-1.2)
nical post-conditioning NYHA, New York Heart Association, LVEF= left
N: blood urea nitrogen, INR: international normalized ratio.
licable. Continuous and ordinal variables were evaluated between two groups
Figure 2 The Kinetics of Cardiac Biomarkers. A; Time Course of
Creatine Kinase (CK). Preoperative CK values were statistically
insignificant for the control and postconditioning groups.
Postoperative 2 hour point, CK values were similar. After 6 hour, CK
levels for the MMPOC group and Control group began to depart
and this significant difference continued to the 12 hour, 24 hour
and 48 hour after the procedure. B; Time Course of Creatine Kinase
Myocard-Brain (CK-MB). Preoperative CK-MB values were statistically
insignificant for the control and postconditioning groups.
Postoperative 2 hour point, CK-MB values for the two groups were
began to differentiated statistically. CK-MB levels for the MMPOC and
Control group were statistically significant for the 6 hour, 12 hour,
24 hour, and 48 hour time points. C; Time Course of Troponin-I (TnI).
Preoperative TnI values were statistically insignificant for the control
and postconditioning groups. Postoperative 2 hour point, TnI values
were similar. After 6 hour, TnI levels for the MMPOC group and
Control group began to depart and this significant difference
continued to the 12 hour, 24 hour and 48 hour after the procedure.
Blue line: Control, Red line: MMPOC.
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The median length of intubation was similar between
the groups (p = 0.818). The MMPOC group patients
had lower length of stay in the ICU and in the hospital
compared to the control group (p<0.001). Importantly,
use of MMPOC shortened postoperative hospitalization
by more than one day. Postoperative complications
were similar in both groups. There were three and fiveperioperative myocardial infarctions in MMPOC and
control groups respectively (p = 0.712). While two hos-
pital deaths were seen in control group, none of the
patients died in MMPOC group (p = 0.499). Wound in-
fection rates, amount of bleeding and postoperative
atrial fibrillation incidences were similar between the
groups as shown in Table 3. The improvement of left
ventricular function in the MMPOC group tended to
decrease requirements for pharmacologic inotropic sup-
port (p = 0.004).
Discussion
This study demonstrates that MMPOC is associated
with increased CI and less cardiomyocyte injury. These
findings are important because previous studies have
demonstrated that low cardiac output, the need for ino-
tropic support, and biochemical evidence of myocyte in-
jury are important risk factors for prolonged ventilation,
ICU stay, and early mortality after CABG [6]. The
requirements for pharmacologic inotropic support dur-
ing the post bypass period reached to statistical signifi-
cance between the groups. Importantly, use of MMPOC
shortened postoperative hospitalization by more than
one day.
In our study, we hypothesized that post conditioning
would provide protection against myocardial ischemia-
reperfusion in adult patients undergoing CPB for CABG
and therefore conducted a controlled trial to evaluate
the effect of post conditioning on myocardial protection.
We applied a new method for the similar hypothesis set
up in the other post-conditioning studies [7-11]. Our
study setting was different compared to the familiar
studies especially for the initiation of the post-
conditioning protocols. Our method started in the time
of weaning from CPB while all the remaining studies
started after aortic declamping. Although larger
Table 2 Intraoperative characteristics
MMPOC (n = 39) Control (n = 40) P value
Operation Time (min) Mean± SD 154.3 ± 17.0 158.3 ± 22.6 0.619
CPB Time (min) Mean± SD 74.1 ± 27.3 81.7 ± 17.0 0.062
Cross Clamp Time (min) Mean± SD 41.2 ± 14.9 44.7 ± 8.9 0.082
IABP n (%) 0 (0) 2 (5) 0.241
No. of graft/patient 2.92 ± 0.83 2.87 ± 0.64 0.974
MMPOC=modified mechanical post-conditioning, SD= standard deviation, CPB, cardio-pulmonary bypass, IABP, intra aortic balloon pump.
Nominal variables were assessed by Chi square test or Fisher’s Exact test, where applicable. Continuous and ordinal variables were evaluated between two groups
by Student’s t test and Mann–Whitney U test, respectively.
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effect of ischemic post conditioning on the reduction
of myocardial necrosis in cardiac surgery, the results
of the study conducted by Luo et al. Provided supportFigure 3 Patients’ Hemodynamic Data. A; Time Course of Cardiac Index
values were statistically insignificant for the control and postconditioning g
significant difference. After 2 hour point, MMPOC group patients’ CI values
Arterial Pressure (MPAP). MPAP values for both groups were statistically ins
Pulmonary Capillary Wedge Pressure (PCWP). PCWP values for both groups
Time Course of Central Venous Pressure (CVP). CVP values for both groups
Blue line: Control, Red line: MMPOC.for ischemic post conditioning as an adjunct to cardio-
plegia in reduction of myocardial necrosis in adult car-
diac surgery [7]. Parallel to the aforementioned studies
and statements, our study investigated the(CI). Effect of MMPOC on recovery of CI after 2 hours. Preoperative CI
roups. Postoperative 2 hour point, CI values for MMPOC group exerted
showed significant improvement. B; Time Course of Mean Pulmonary
ignificant from the beginning of the procedure. C; Time Course of
were statistically insignificant from the beginning of the procedure. D;
were statistically insignificant from the beginning of the procedure.
Table 3 Postoperative characteristics
MMPOC (n= 39) Control (n = 40) P Value
Postoperative inotropes n (%) 19 (48) 32 (80) 0.004
IABP n (%) 2 (5) 4 (10) 0.675
Bleeding (ml) Mean± SD 569.2 ± 120.5 545.6 ± 97.1 0.214
Mechanical Ventilation (hrs) Mean± SD 12.0 ± 3.22 15.6 ± 3.21 0.818
ICU (hrs) Mean± SD 15.8 ± 2.3 18.8 ± 3.7 0.000
Postoperative MI n (%) 3 (7.7) 5 (12.5) 0.712
Hospitalization (days) Mean± SD 7.5 ± 1.6 9.1 ± 2.1 0.001
Wound Infection n (%) 4 (10) 2 (5) 0.432
Atrial Fibrillation n (%) 6 (15) 5 (12.5) 0.711
In-hospital mortality n (%) 0 (0) 2 (5.0) 0.499
MMPOC=modified mechanical post-conditioning, IABP= intra aortic balloon pump, ICU= intensive care unit, SD= Standard Deviation.
Nominal variables were assessed by Chi square test or Fisher’s Exact test, where applicable. Continuous and ordinal variables were evaluated between two groups
by Student’s t test and Mann–Whitney U test, respectively.
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going elective coronary revascularization. The current
study focused on cardiac biomarker release after
CABG surgery. Application of MMPOC prevented the
post-bypass increases in TnI, CK and CK-MB.
In our study, to overcome the problem of predicting the
volume of at-risk myocardium or collateral perfusion into
the ischemic area, we planned to surmount this potentially
confounding factor by including only those patients exhibit-
ing proximal occlusion of the LAD artery with or without
occlusions of the other coronary arteries as indicated by
Darling et al [12]. It can be hypothesized that the better
preservation of cardiac function obtained by MMPOC evi-
denced by data on reduced postoperative TnI release and
the reduced need for inotropic support resulted in
improved global tissue perfusion with better recovery from
surgery as shown by shorter postoperative hospitalization.
The mechanisms underlying the benefits of MMPOC are
similar to other mechanical POC techniques described be-
fore with the advantage of not requiring repetitive aortic
cross-clamping.
Post-conditioning as with ischemic preconditioning has
the drawback of intermittent cross-clamping which
prompted us to modificate the original technique. Unlike
pre-conditioning, post-conditioning does not require initi-
ation prior to the ischemic event. This aspect offers several
interesting opportunities to the cardiac surgeon. Post-
conditioning can be used in situations where precondition-
ing is difficult or impossible to achieve. The cardiac trans-
plant surgeons can also benefit from post-conditioning.
The storage time of the cardiac allograft can often exceed
the protective effects of early pre-conditioning and there-
fore, post-conditioning may play an important role for allo-
graft protection following storage and transplantation.
Remote post-conditioning has also been demonstrated in
an animal model [13]. Kerendi et al. demonstrated in a ro-
dent model that remote post-conditioning using renalartery occlusion reduced infarct size by 50% [13]. Ischemic
post-conditioning requires intermittent cross-clamping of
another organ to protect the myocardium which may be
associated with morbidity or increased complexity and
length of the operative procedure. The optimal post-
conditioning strategy would be pharmacologic. In this re-
spect a variety of diverse pharmacological post-
conditioning agents including inhalational anesthetics, G-
protein coupled receptor ligands such as opioids, adenosine
and bradykinin, growth factors such as insulin and erythro-
poietin, natriuretic peptides, adipocytokines, and statins
have been linked to the activation of the reperfusion injury
salvage kinase pathway, a critical component of this signal-
ing pathway [14,15].
Pharmacological post-conditioning would avoid the ad-
verse consequences associated with intermittent cross-
clamping and provide a simple method of myocardial pro-
tection following all cardiac procedures. A potential draw-
back of post conditioning is that it offers protection after
the ischemic insult has occurred and by then, the myocar-
dial injury may be so extensive that post conditioning is of
little benefit [13].
The heightened sensitivity and specificity of TnI and of
CK-MB have rendered such markers ideal in revealing a
cardiac injury following an ischemic insult of a different na-
ture. Intraoperative TnI release has a functional significance
because it is closely related to ischemic time and reflects
delayed recovery of left ventricular function and oxidative
metabolism; therefore, its measurement can be used as an
indicator of myocardial injury sustained during CABG [16].
A recent study by Luo et. al showed the postoperative re-
lease of CK-MB was significantly decreased in POC patients
undergoing valve replacement [7]. Moreover, in another
study, the same group showed the beneficial effects of POC
in a patient subgroup undergoing surgery for tetralogy of
Fallot [8]. The major finding of that study is that POC
reduced postoperative peak release by 34% for CK-MB and
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myocardial injury. Another study conducted by Kin et. al
demonstrated that pharmacologic post conditioning with
adenosine administered through an arterial catheter during
CPB produces protective effects against myocardial reperfu-
sion injury in cardiac operations [17]. A possible mechan-
ism of protection, namely, prevention of endothelial
ischemia-reperfusion injury by POC was shown by recent
studies [18,19].
Conclusion
We suggest that these cardioprotective effects of MMPOC
could have clinical implication in terms of clinical outcome
(reduced postoperative length of stay) in CABG operations.
Significantly shorter hospital stays will certainly result in
lower total hospital costs and nosocomial infections. It can
be an adjunct to the other regimes of cardioprotection. Fur-
thermore, our study includes moderately high risk patients
with impaired left ventricular ejection faction, medium
EuroSCORE and high New York Heart Association
(NYHA) status. We assume that improvement in clinical
outcome after CABG for patients treated with MMPOC
could be demonstrated in a larger study involving patents
with worse left ventricular function.
Briefly, our MMPOC technique adjusted after CPB
promotes early metabolic recovery of the heart during
elective CABG and leads to better myocardial protection
and functional recovery.
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